A detailed history of M. Kulyk & Associates, LLC transactions in Baxter International Inc stock. As of the latest transaction made, M. Kulyk & Associates, LLC holds 136,093 shares of BAX stock, worth $4.74 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
136,093
Previous 137,468 1.0%
Holding current value
$4.74 Million
Previous $5.22 Million 23.97%
% of portfolio
0.89%
Previous 1.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

SELL
$28.63 - $37.84 $39,366 - $52,030
-1,375 Reduced 1.0%
136,093 $3.97 Million
Q3 2024

Nov 07, 2024

SELL
$32.85 - $40.26 $22,108 - $27,094
-673 Reduced 0.49%
137,468 $5.22 Million
Q2 2024

Aug 05, 2024

BUY
$32.87 - $43.55 $785,165 - $1.04 Million
23,887 Added 20.91%
138,141 $4.62 Million
Q1 2024

May 09, 2024

BUY
$37.88 - $43.77 $118,185 - $136,562
3,120 Added 2.81%
114,254 $4.88 Million
Q4 2023

Feb 08, 2024

BUY
$31.71 - $38.95 $589,266 - $723,807
18,583 Added 20.08%
111,134 $4.3 Million
Q3 2023

Nov 07, 2023

BUY
$37.32 - $49.29 $426,306 - $563,039
11,423 Added 14.08%
92,551 $3.49 Million
Q2 2023

Aug 08, 2023

BUY
$39.98 - $47.68 $722,158 - $861,243
18,063 Added 28.64%
81,128 $3.7 Million
Q1 2023

May 08, 2023

BUY
$37.58 - $52.57 $222,774 - $311,634
5,928 Added 10.38%
63,065 $2.56 Million
Q4 2022

Feb 08, 2023

BUY
$49.7 - $57.71 $106,606 - $123,787
2,145 Added 3.9%
57,137 $2.91 Million
Q3 2022

Nov 07, 2022

BUY
$53.86 - $66.8 $856,427 - $1.06 Million
15,901 Added 40.68%
54,992 $2.96 Million
Q2 2022

Aug 05, 2022

BUY
$63.83 - $80.0 $330,256 - $413,920
5,174 Added 15.25%
39,091 $2.51 Million
Q1 2022

May 11, 2022

BUY
$76.85 - $89.45 $2.4 Million - $2.8 Million
31,280 Added 1186.2%
33,917 $2.63 Million
Q4 2021

Jan 20, 2022

BUY
$74.57 - $87.19 $196,641 - $229,920
2,637 New
2,637 $226,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track M. Kulyk & Associates, LLC Portfolio

Follow M. Kulyk & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kulyk & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M. Kulyk & Associates, LLC with notifications on news.